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ABSTRACT
X-ray crystal structures were determined of
the broad-spectrum aminoglycoside-resistance
A1408 16S rRNA methyltransferases KamB
and NpmA, from the aminoglycoside-producer
Streptoalloteichus tenebrarius and human patho-
genic Escherichia coli, respectively. Consistent
with their common function, both are Class I
methyltransferases with additional highly conserved
structural motifs that embellish the core
SAM-binding fold. In overall structure, the A1408
rRNA methyltransferase were found to be most
similar to a second family of Class I methyl-
transferases of distinct substrate specificity
(m
7G46 tRNA). Critical residues for A1408 rRNA
methyltransferase activity were experimentally
defined using protein mutagenesis and bacterial
growth assays with kanamycin. Essential residues
for SAM coenzyme binding and an extended
protein surface that likely interacts with the 30S
ribosomal subunit were thus revealed. The struc-
tures also suggest potential mechanisms of A1408
target nucleotide selection and positioning. We
propose that a dynamic extended loop structure
that is positioned adjacent to both the bound SAM
and a functionally critical structural motif may
mediate concerted conformational changes in
rRNA and protein that underpin the specificity of
target selection and activation of methyltransferase
activity. These new structures provide important
new insights that may provide a starting point for
strategies to inhibit these emerging causes of
pathogenic bacterial resistance to aminoglycosides.
INTRODUCTION
Bacterial antibiotic resistance is a major contemporary
clinical challenge that demands urgent studies of
the activities and origins of resistance determinants.
A variety of mechanisms, often found in combination,
confer resistance by reducing the effective drug concentra-
tion in the cell by transport or modiﬁcation, or altering the
drug binding site through mutation or chemical modiﬁca-
tion (1).
The protein translation machinery is the target of
many classes of antibacterial agents. For example,
aminoglycoside antibiotics bind to the 30S ribosomal
subunit A site, inducing errors in decoding, occluding
the mRNA path or inhibiting mRNA:tRNA translocation
(2). These diverse molecules can be collected into three
broad groups: the 4,6-disubstituted deoxystreptamines
(4,6-DOS) including kanamycin, tobramycin and gentami-
cin; the 4,5-disubstituted deoxystreptamines (4,5-DOS)
such as paromomycin and neomycin; and a third
more diverse group with alternative cores or ring
arrangements, such as apramycin or streptomycin. Two
families of S-adenosyl-L-methionine (SAM)-dependent
aminoglycoside-resistance methyltransferases act upon
16S rRNA to produce either an N7-methyl G1405
(m
7G1405) or N1-methyl A1408 (m
1A1408) modiﬁcation.
Whereas the resistance spectrum conferred by m
7G1405 is
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and gentamicin), the m
1A1408 modiﬁcation confers a
broad resistance spectrum that includes examples of the
4,6-DOS (e.g. kanamycin but not gentamicin) and
4,5-DOS aminoglycoside groups and also apramycin (3).
The G1405 and A1408 16S rRNA aminoglycoside-
resistance methyltransferases were ﬁrst identiﬁed in
antibiotic producing bacteria, where they act to protect
against self-intoxication (4). However, they are now
increasingly being identiﬁed in both animal and
human pathogens (5,6). The transfer and world-wide
dissemination among pathogenic bacterial populations
of the Erm methyltransferases, that methylate A2058
of 23S rRNA to confer a Macrolide–Lincosamide–
Streptogramin B (MLSB) resistance phenotype, severely
restricts the clinical utility of these drugs (7). The recent
identiﬁcation of pathogen aminoglycoside-resistance 16S
rRNA methyltransferases, often associated with mobile
genetic elements, suggests that the aminoglycoside family
of antibiotics is now similarly threatened by the increasing
prevalence of these enzymes (8,9).
Recent bioinformatic analysis and modeling of the
A1408 methyltransferase KamB from Streptoalloteichus
hindustanus identiﬁed an adjustment to the 50-end of the
open reading frame that would be required to produce an
intact Class I methyltransferase SAM-binding fold (10).
This observation facilitated the ﬁrst recombinant expres-
sion of a KamB protein in our laboratory (3). These
studies provided initial experimental veriﬁcation that the
A1408 methyltransferases are indeed members of the Class
I methyltransferases, a large group that modify diverse
substrates including numerous rRNA, tRNA, DNA and
many small molecules (11). Substrate speciﬁcity in these
enzymes is thought to arise through the varied embellish-
ments to the core fold which can be present at either
terminus or in the loops between core b-strands.
In addition to the Kam family of four distinct A1408
methyltransferases from aminoglycoside-producers, one
conﬁrmed enzyme of apparently identical function,
NpmA, has been identiﬁed in human pathogenic
Escherichia coli (ARS3) from a clinical isolate (9).
Phylogenetic analysis also clusters CmnU and Kmr from
the capreomycin-producer Saccharothrix mutabilis subsp.
capreolus (12) and the cellulose degrading bacterium
Sorangium cellulosum (13), respectively, and two addition-
al hypothetical proteins with the ﬁve known A1408
methyltransferases (Supplementary Figure S1). However,
these enzymes have not been demonstrated to possess
A1408 methyltransferase activity. Inference of such
activity from sequence information in the absence of func-
tional characterization must be made with caution since
sequence identity is relatively low even among the ﬁve
conﬁrmed A1408 rRNA methyltransferases. Most import-
antly, the critical structures outside of the core
SAM-binding fold and the speciﬁc residues that deﬁne
the A1408 methyltransferase activity are not known.
Here, we describe the high-resolution crystal structures
and functional analysis of KamB from the nebramycin
producer Streptoalloteichus tenebrarius (14,15) and its
pathogen ortholog NpmA (9). With recent reports of
two complete structures of the G1405 methyltransferases,
RmtB (16) and Sgm (17), a complete structural character-
ization of both enzyme families from both aminoglycoside
producer and pathogenic bacteria is now available. Our
studies provide new insights into the likely molecular
mechanisms of action of the A1408 methyltransferases,
and reveal unexpected structural similarities outside of
the core Class I methyltransferase fold to another RNA
methyltransferase family of different target nucleotide
modiﬁcation (m
7G) and substrate speciﬁcity (tRNA).
MATERIALS AND METHODS
Protein crystallization and structure determination
KamB and NpmA proteins were overexpressed in strain
BL21(DE3) from pET44 plasmid constructs containing
E. coli optimized genes produced by chemical synthesis
(GeneArt). Selenomethionine KamB was also
overexpressed in strain BL21(DE3) using Overnight
Express (Novagen) autoinduction media supplemented
with 30mg/l seleno-L-methionine. All proteins were
puriﬁed to homogeneity using the same two-step proced-
ure involving heparin afﬁnity and gel ﬁltration
chromatographies (N.V.Zelinskaya et al., submitted for
publication).
Crystallization was performed by sitting drop vapor
diffusion at 20 C using KamB or NpmA (10mg/ml) with
1mM SAM in Tris buffer (pH 8.0 and 7.0, respectively)
and 150mM NaCl. KamB crystals were grown in Tris–
HCl buffer pH 8.0 containing 250mM KSCN and 24%
polyethylene glycol (PEG) 2000 monomethylether, and
cryoprotected using the same conditions supplemented
with 25% PEG 400. NpmA crystals were grown in
100mM HEPES buffer pH 7.5 with 14% PEG 6000 and
4% MPD and adequate cryoprotection was achieved by
increasing the MPD to ﬁnal 25% concentration. All diffrac-
tion data were collected at the Advanced Photon Source
SER-CAT beamline BM-22 and processed using HKL2000
(18). Single wavelength anomalous diffraction (SAD) data
for experimental phasing using selenomethionine-KamB
was collected at 0.97911A ˚ (selenium K edge peak).
Identiﬁcation of the selenium sites and initial model
building of KamB was performed using Phenix (19) with
further automated building using ARP/wARP (20) and
manual building in Coot (21) to complete the structure.
The core KamB SAM-binding domain structure was used
as a molecular replacement model in Phaser (22), and the
NpmA structure completed using Coot (21). Reﬁnement
of both structures against high resolution native data was
performed using Phenix (23), employing TLS reﬁnement
in the ﬁnal stages (24). Complete data collection and pro-
cessing and structure reﬁnement statistics are provided in
Table 1.
Analysis of KamB protein fold similarity to other
protein structures was performed using the DALI server
(25). Modeling of potential A1408 interactions with
KamB was performed using HADDOCK (26).
Mutagenesis and MIC assays
Site-directed mutagenesis of KamB was performed in the
pQE30 vector (Qiagen) using the QuikChange Lightning
7792 Nucleic Acids Research, 2010,Vol.38, No. 21kit (Stratagene). Minimum inhibitory concentrations
(MIC) of kanamycin were measured in liquid culture for
E. coli BL21(DE3) transformed with empty pQE30 vector
or pQE30 encoding wild-type or mutant KamB proteins.
Initial cultures for each experiment were grown to satur-
ation in LB medium supplemented with 50mg/ml ampi-
cillin. Fresh LB medium (10ml) containing various
concentrations of kanamycin (0–1200mg/ml) was inocu-
lated at 1:1000 dilution using each starter culture and
incubated at 37 C for 16h with vigorous shaking.
Assays were performed at least in triplicate and the MIC
was deﬁned as the lowest concentration of kanamycin for
which no growth could be detected (A600<0.05).
RESULTS
Crystal structures of KamB–SAH and
NpmA–SAM complexes
KamB (215 amino acids) was crystallized in the presence
of SAM and the complex structure determined at 1.69A ˚
using experimentally determined phases (Table 1). NpmA
(219 amino acids) was also co-crystallized with SAM and
its structure determined to 1.8A ˚ by molecular replacement
using our KamB structure as a model. Both structures
were reﬁned with good statistics (Table 1). In both
crystals, the asymmetric unit contained two molecules
with clear continuous density allowing modeling of all
amino acids in both copies of KamB and NpmA. The
bound SAM molecule was clearly deﬁned in the NpmA–
SAM complex (Figure 1A). For KamB, coenzyme was
present at partial occupancy and the absence of any
density for the methyl group suggested that the methyla-
tion reaction by-product S-adenosylhomocysteine (SAH)
was present, as previously observed in crystal structures of
other rRNA methyltransferases crystallized in the
presence of SAM (16,27).
The structures of KamB and NpmA (Figure 1B and C)
deﬁnitively conﬁrm both as Class I methyltransferase
enzymes that possess a characteristic Rossmann-like
SAM-binding fold of a seven-stranded b-sheet with
central topological switch point (6"7#5"4" 1"2"3")
ﬂanked by a-helices (11). KamB and NpmA are also es-
sentially identical in the N-terminal domain and extended
loop structures that append this structurally conserved
core fold (Figure 1D,E) with an r.m.s.d. for alignment
of all 215 Ca of 2.5A ˚ . Only the extended loop between
b-strands 5 and 6 (Loop b5–b6) shows any signiﬁcant
structural variability and excluding this loop from the
alignment reduces the r.m.s.d. to 1.8A ˚ for the remaining
atom pairs. While this loop is similar in both molecules
of KamB, with little deﬁned secondary structure, for
NpmA each copy of the protein possesses a distinct loop
conformation that contains an a-helix (Supplementary
Figure S2). In NpmA chain A, where this loop is more
constrained by crystal packing contacts, it forms an exten-
sive a-helix positioned closely against the rest of the
protein with contacts to the adjacent short parallel
a-helix of the loop between b-strands 4 and 5 (Loop b4–
b5). Interactions are made to each end of the Loop b4–b5
helix, including a hydrogen bond between Glu146 and the
peptide backbone of Gly108, and a salt bridge between
Arg153 and Glu112 (Supplementary Figure S2). In
contrast, in NpmA chain B where this loop is less re-
stricted, the a-helix is shortened and the loop extends
away from the core fold by up to 8A ˚ , disrupting these
interactions. This apparent structural plasticity may
be important for A1408 rRNA methyltransferase
function (see ‘Discussion’ section).
The Rossmann-like Class I methyltransferase core fold
is elaborated with two further additional structural motifs
at the N-terminus and between b-strands 6 and 7 (Loop
b6–b7; Figure 1E and Supplementary Figure S3). While
the N-terminal b-hairpin is present in both structures and
modestly conserved in sequence (Supplementary Figure
S4), we do not believe it is likely to play a signiﬁcant
role in deﬁning the function of the enzyme. In contrast,
structural insertions between b-strands 6 and 7 are known
to inﬂuence target selection and speciﬁcity in other Class I
methyltransferases (11) and our structures and functional
data, described below, suggest such a role for this
extended loop in the A1408 rRNA methyltransferases.
Proteins of similar fold to KamB and NpmA were
identiﬁed using the Dali server (25) and as expected the
vast majority of retrieved structures were Class I
methyltransferases (Z-score range 5.6–13.5). The greatest
similarity was identiﬁed with the m
7G46 tRNA
Table 1. Complete X-ray data collection and structure reﬁnement
statistics
SeMet KamB KamB–SAH NpmA–SAM
Space group P21 P21 P21
Resolution (A ˚ ) 2.00 1.69 1.80
Cell dimensions
a, b, c (A ˚ ) 48.6, 64.2, 71.6 48.3, 64.1, 72.0 49.7, 59.8, 91.7
a, b, g ( ) 90, 104.1, 90 90.0, 104.6, 90.0 90, 96.3, 90
Wavelength 0.97911(Peak) 1.0 1.0
Resolution (A ˚ )
a 50–2.0 (2.07–2.0) 50–1.69 (1.75–1.69) 50–1.80 (1.87–1.80)
Rmerge
b 0.169 (0.501) 0.05 (0.285) 0.067 (0.395)
I/sI 17.4 (6.3) 16.8 (3.4) 20 (3.4)
Completeness (%) 100 (100) 99.1 (92.0) 99.9 (99.7)
Redundancy 9.9 (9.0) 3.8 (3.6) 4.6 (4.3)
Figure of Merit
c 0.31 – –
No. reﬂections 46638 49392
Rwork/Rfree
d 17.2/20.2 17.8/20.6
Number of atoms
Protein 3431 3621
Ligand/ion 52 54
Water 283 242
B-factors
Protein 19.89 29.43
Ligand/ion 15.91 28.44
Water 25.92 35.69
Ramachandran Plot
Favorable (%) 99.1 98.9
Allowed (%) 0.9 1.1
R.m.s. deviations
Bond lengths (A ˚ ) 0.006 0.007
Bond angles ( ) 1.108 1.050
aValues in parenthesis are for the highest resolution shell.
bRmerge = hkl i|Ii (hkl)–hI(hkl)i|/hkl iI i (hkl).
cFigure of merit (FoM) m ¼ cos      ðbestÞ

dRwork = hkl|Fo (hkl)–Fc (hkl)|/hkl| Fo (hkl), where Fo and Fc are
observed and calculated structure factors, respectively. Rfree, applies to
the 5% of reﬂections chosen at random to constitute the test set.
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subtilis TrmB (Z-score 16.2; PDB code 2FCA). Like the
m
1A1408 methyltransferases, the m
7G46 tRNA
methyltransferases possess a short N-terminal extension
and a structurally similar Loop b6–b7 (Supplementary
Figure S5). Thus these structures align very well
(r.m.s.d. 2.7A ˚ ). In contrast, the m
7G1405
aminoglycoside-resistance methyltransferase RmtB was
ranked much lower in structural similarity, appearing on
the list of retrieved structures well below many other Class
I methyltransferases that modify tRNA, DNA, proteins or
small molecules.
Critical residues for A1408 methyltransferase function
Using both the structures and amino acid conservation
between KamB and NpmA as a guide, 22 putative key
residues for A1408 methyltransferase function in SAM
binding and target selection or modiﬁcation were
identiﬁed (Table 2). Each was individually mutated to
alanine, with Trp105 and Trp193 additionally mutated
to phenylalanine, and the mutant proteins tested for
their ability to support bacterial growth in liquid culture
in the presence of kanamycin (0–1200mg/ml).
SAM binding. KamB and NpmA each contain a
conserved GXGXG sequence (amino acids 32–36) within
Figure 1. X-ray crystal structures of A1408 aminoglycoside-resistance rRNA methyltransferases. (A) SAM in omit 2Fo–Fc electron density contoured
at 1.0s. Wall-eye stereo views of the (B) KamB–SAH and (C) NpmA–SAM complexes. Bound SAH or SAM molecules are shown as yellow sticks.
(D) Alignment of KamB (orange) and NpmA (light cyan) crystal structures with b-strands of the Rossmann-like core SAM-dependent
methyltransferase fold and the protein termini indicated. (E) Cartoon of the KamB–SAH complex with the three extended structural motifs on
the core fold highlighted (orange). The view shown is rotated  180  about the vertical axis from the orientation of panel B.
Table 2. Mutagenesis and analysis of KamB activity in liquid culture
Proposed Function Plasmid/
mutation
Kanamycin
MIC (mg/ml)
Control Empty pQE30 10
pQE30–KamB >1200
RNA/30S Binding R8A >1200
K37A 50
K58A 800
K63A 800
K67A 400
K71A 400
K74A 200
K174A >1200
R179A 800
R195A 400
R196A 10
R201A 10
R203A 800
SAM binding D30A 20
D55A 10
R60A 800
E88A 400
S107A 800
T191A 10
A1408 Positioning/catalysis W105A 10
W105F 10
N138A 100
W193A 10
W193F 10
7794 Nucleic Acids Research, 2010,Vol.38, No. 21their methyltransferase ‘Motif I’, that forms part of the
SAM-binding site. In KamB, one additional residue from
this motif, Asp30, forms a water-mediated hydrogen bond
that positions the SAH terminal amino group, while the
carboxylate is within hydrogen bonding distance of both
Arg60 and Thr191 (Figure 2A). The adenine ring is
enclosed on its Hoogsteen edge by Glu88 and Ser107. A
very similar set of interactions deﬁnes the SAM-binding
pocket in NpmA (Supplementary Figure S6). Mutations
to alanine conﬁrmed the critical nature of Asp30, Asp55
and Thr191 in forming the SAM-binding pocket through
the inability of the mutant enzymes to support growth
at even the lowest kanamycin concentrations tested
(Table 2). The water-mediated interaction of Asp30 has
been observed in structures of several methyltransferases
that act on mRNA (PDB code 1RI4), tRNA (PDB code
3DXY) and DNA (PDB code 3MHT). Mutations at
Arg60, Glu88 and Ser107 result in more modest reduc-
tions in the enzyme’s ability to support bacterial growth
in the presence of kanamycin. This suggests that hydro-
phobic stacking interactions are most signiﬁcant in pos-
itioning the adenine moiety of SAM, or that precisely
recognizing and positioning the nucleobase is less critical
than for the ribose and methionine moieties.
Target recognition and methylation. The intact 30S
subunit is the minimal substrate for methylation by
A1408 methyltransferases (28), suggesting that these
enzymes recognize one or more RNA structures that
are formed or become adjacent only in the fully assembled
subunit. Thirteen surface lysine and arginine residues
in KamB were mutated to alanine to identify the protein
surface that interacts directly with the 30S subunit.
The mutated residues are distributed over several struc-
tural motifs in the protein, but most are clustered on
a single surface forming an extended positively charged
patch (Figure 2B). Two mutations, Arg8 and Lys174
to alanine, produced proteins with an activity indistin-
guishable from wild-type in the MIC assay. The former
result suggests that the N-terminal b-hairpin extension to
the core Rossmann-like fold is not critical for speciﬁc
A1408 methyltransferase function. The majority of the
mutated proteins confer a range of resistance levels with
kanamycin MICs decreased at least 1.5- to 12-fold (Table
2). However, two mutant proteins with alanine substitu-
tions at Arg196 and Arg201 confer no resistance to even
the lowest kanamycin concentration (Table 2). This result
clearly implicates these residues and the Loop b6–b7
extended structure as critical determinants of enzyme
function such as rRNA recognition or speciﬁc target site
selection.
Examination of the protein surface surrounding the
bound coenzyme identiﬁed a pocket that might potentially
accommodate A1408 adjacent to the methyl group for
transfer. Two conserved tryptophans, 105 and 193, line
this pocket (Figure 2A) and we hypothesized that they
might play a role in the correct positioning of the target
nucleoside. In support of this, mutation of either residue
to alanine or, more conservatively, to phenylalanine
completely abolished enzyme activity in the MIC assay
(Table 2). We next used the HADDOCK webserver (26)
to model an adenine nucleotide in the pocket between
these two residues, which resulted in the positioning of
adenine N1 3.7A ˚ from the methyl group of the modeled
SAM (Figure 3). Similar experiments with larger frag-
ments of helix 44 failed to produce a satisfactory position-
ing of the adenine N1 relative to the SAM methyl group
(closest approach  12A ˚ ) indicating that A1408 must to be
‘ﬂipped’ from helix 44 in order to be correctly positioned
adjacent to the bound SAM for methyl group transfer.
The model also suggests that one or both of these
conserved Trp residues may serve as a platform to
position the adenine ring in the enzyme active site.
Trp193 is located in the extended Loop b6–b7 structure,
adjacent to the critical Arg196, and could readily interact
with A1408 (Figure 3). We also note that Trp107 in
NpmA (equivalent to KamB Trp105), clearly adopts two
distinct alternate conformations in chain A, where the
adjacent ﬂexible Loop b5–b6 is in the extended conform-
ation, but not in chain B where the loop is more compact
Figure 2. Critical residues for A1408 rRNA methyltransferase function. (A) Cartoon of the KamB structure surrounding the bound SAH. Residues
proposed to be important for enzyme function through formation of the SAM-binding pocket (orange) or in A1408 target nucleotide positioning in
the enzymatic center (green) are highlighted. (B) Multiple views of the KamB electrostatic surface representation (left) and cartoon (right) showing
basic residues (blue) mutated to test their putative role in interaction with 30S ribosome subunit. The boxed surface orientation corresponds to the
cartoon view (left). The coenzyme is modeled as SAH (yellow sticks). The effect of mutation at each indicated residue on kanamycin MICs is shown
in Table 2.
Nucleic Acids Research, 2010,Vol.38, No. 21 7795(Supplementary Figures S2 and S7). Thus a number of
plausible mechanisms can be envisaged by which speciﬁc
target nucleotide selection might be coupled through
dynamic changes in both protein and rRNA upon
binding to activate the methyltransferase reaction (see
‘Discussion’ section)
One additional residue, Asn138, previously identiﬁed as
having a potential role in catalysis (10), is also located
adjacent to the modeled A1408 nucleotide. The KamB
protein with an Asn138 to alanine mutation was indeed
considerably less effective in the MIC assay (>12-fold
reduced; Table 2). However, despite its proximity to the
catalytic center, the residue is unlikely to be directly
involved in the nucleobase modiﬁcation reaction. The
equivalent residue in NpmA is Thr140 and thus lacks
the side chain amino group of Asn138 which is oriented
toward the A1408 nucleobase in the modeled complex
with KamB. However, a hydrogen bonding interaction
with the amide backbone at Asp205 (Ser208 in NpmA)
is conserved for both Asn138 and Thr140. Thus, the
likely role of this residue is maintenance of a structurally
critical interaction between the two extended structural
motifs that deﬁne the functional speciﬁcity of the A1408
rRNA methyltransferases.
Sequence analysis corroborates the structural link to
m
7G46 tRNA methyltransferases
The KamB and NpmA protein sequences were used as
search subjects in FlowerPower (29), a clustering algo-
rithm that can identify homologous sequences with
similar domain architectures. The sequences retrieved
were used in a BLAST search and a phylogenetic related-
ness inferred for a subset of the returned sequences after
reduction of sequence redundancy (Supplementary
Figure S8). The maximum likelihood (ML) phylogenetic
reconstruction showed a division of the analyzed se-
quences in two major clades: one comprising the
m
1A1408 resistance methyltransferases and the second
the m
7G46 tRNA methyltransferases. Thus the high struc-
tural relatedness identiﬁed via the Dali server using our
KamB and NpmA structures is recapitulated by sequence
analysis. Curiously, however, using the B. subtilis TrmB
sequence in a reverse FlowerPower search failed to
retrieve any aminoglycoside-resistance A1408 rRNA
methyltransferase.
Finally, from our combined structure–function and
sequence alignment analyses we can address the likelihood
of putative A1408 methyltransferases (Supplementary
Figures S1 and S8) to possesses this speciﬁc activity.
While there are some exceptions, the majority of
residues where mutation most affects enzyme activity are
conserved in these proteins despite their relatively low
sequence similarity (Supplementary Figure S4). Thus,
our results add structure-function validation for the inclu-
sion of these additional enzymes in the A1408 family and
suggest that they are bona ﬁde rRNA methyltransferases
acting at A1408.
DISCUSSION
Despite their prevalence among antibiotic-producing
bacteria and emergence in the last decade as a new
threat to the clinical use of aminoglycosides, until
recently few structural or functional details were
known about the A1408 and G1405 families of
resistance rRNA methyltransferases. However, initial
modeling and mutagenesis studies on both families
(10,30,31) were very recently followed by crystal structures
of G1405 methyltransferases of pathogenic (16) and
aminoglycoside-producer origin (17). The present studies
complete the structural characterization of the second
aminoglycoside-resistance rRNA methyltransferase
family and allow direct comparison of the likely mechan-
isms of action between the two enzyme families.
As predicted by previous sequence analyses, both
producer and pathogenic bacterial A1408 and G1405
aminoglycoside-resistance methyltransferases are Class I
SAM-dependent methyltransferases. These enzymes all
possess a characteristic Rossmann-like core SAM-
binding fold (11). However, the structural embellishments
around this core fold differ signiﬁcantly between the
G1405 and A1408 enzymes but are highly conserved
within each family between enzymes of aminoglycoside-
producer and pathogenic origin. The concept that
aminoglycoside-resistance 16S rRNA methyltransferases
found in pathogenic bacteria arose following horizontal
transfer from an aminoglycoside-producer is clearly sup-
ported by this high structural conservation. However, with
a G/C content of only 34%, the origin of the only current-
ly known A1408 methyltransferase gene npmA appears
unlikely to be the G/C-rich actinomycete, where  70%
G/C content is typical for known 16S rRNA
methyltransferases. The A1408 methyltransferases show
Figure 3. Model of A1408 bound in the KamB active site. An adenine
nucleoside was docked into a surface pocket formed in part by the
conserved and critical Trp105 and Trp193 residues. The adenine N1
is positioned 3.7A ˚ from the modeled methyl group (double arrow).
Essential arginine residues 196 and 201 for A1408 methyltransferase
activity in the adjacent extended structural motif in Loop b6–b7 are
indicated and the ﬂexible Loop b5–b6 is highlighted in orange.
7796 Nucleic Acids Research, 2010,Vol.38, No. 21strong structural similarity to m
7G46 tRNA methyl-
transferases outside of the core SAM-binding fold, sug-
gesting the possibility that these enzymes evolved from
a common ancestor, for example by gene duplication
and divergence of methylation target. This link was
corroborated in parallel using sequence-based searches
with KamB and NpmA, but the reverse search using the
tRNA modifying enzyme sequence did not retrieve any
A1408 rRNA methyltransferase. This indicates that
there is signiﬁcant divergence from any such common
ancestor and that these enzymes evolved independently
in function while maintaining the overall protein fold.
However, this observation does provide an alternative
molecular evolutionary route to A1408 methyl-
transferases in pathogenic bacteria other than the direct
horizontal transfer of a resistance enzyme from an
aminoglycoside-producing strain.
The A1408 and G1405 methyltransferases do not
methylate naked 16S rRNA, nor will they bind or methy-
late model helix 44 fragments despite the structural
similarity of the isolated domain to the structure in the
30S subunit. Given the close proximity of the two target
nucleotides, their respective methyltransferases must pre-
sumably recognize many of the same features of the
30S subunit architecture around helix 44 (Figure 4).
Outside of their structurally conserved Class I
methyltransferase SAM-binding domain core, the G1405
and A1408 enzymes differ signiﬁcantly in structure
(Figure 4). The G1405 methyltransferases are  5kDa
larger and possess an extended N-terminal structure
divided into two subdomains termed ‘N1’ and ‘N2’ (16).
The enzyme activity is abolished in the absence of the N1
three-helix bundle and it is proposed that this domain is
critical for binding 30S. In contrast, the A1408
methytransferases lack a large functionally important
N-terminal extension and, instead, have extended struc-
tural motifs between b-strands 5 and 6, and b-strands
6 and 7. The latter structural motif, that was found
here to contain three amino acids critical for A1408
methyltransferase function (Trp193, Arg196 and Arg201
in KamB), is completely absent in all examples of the
G1405 methyltransferases structurally characterized to
date. Thus the m
7G1405 and m
1A1408 methyltransferase
families appear to employ substantially different mechan-
isms to recognize and select their target nucleotide.
Comparison of the KamB and NpmA structures
allows us to speculate further on the mechanism of
speciﬁc target selection for the A1408 methyltransferases.
In the 30S subunit, A1408 is stacked in helix 44 opposite
A1492 and A1493, such that the nucleobase would need
to be ‘ﬂipped’ into the enzyme active site, in common
with several other nucleic acid modifying enzymes (32)
and recently proposed for the G1405 resistance
methyltransferases (17). Superposition of KamB onto
the methyltransferase HhaI (PDB code 3MHT) (33)
bound to DNA, positions the extended structural motif
of Loop b5–b6 (residues 141–156) next to the major
groove of the nucleic acid helix. We suggest that this
loop structure directly contributes to recognition and
ﬂipping of the A1408 conformation, and that the struc-
tural plasticity we observe is important for this role. In the
NpmA crystal, where this loop is unrestrained by packing
contacts, it forms an extended structure with a short helix
that could represent an initial recognition conformation.
In contrast, when packed against the 30S surface the struc-
ture folds more compactly against the active site of the
enzyme, mimicked by crystal packing contacts for
NpmA chain A. Because this loop makes direct contacts
Figure 4. A1408 and G1405 aminoglycoside-resistance methyltransferases and their target sites in the 30S subunit. The distinct structural embel-
lishments on the core Rossmann-like SAM binding core that deﬁne the structures of G1405 (red) and A1408 (orange) are highlighted on the RmtB
(PDB code 3FRH) and KamB structures, respectively. Right, the methylation target sites shown surrounded by the common 30S architectural
features that must be recognized by these enzymes. This surface is composed primarily of distant 16S rRNA helices, brought into proximity in the
assembled 30S, and one ribosomal protein, S12.
Nucleic Acids Research, 2010,Vol.38, No. 21 7797with other regions of the protein implicated in target rec-
ognition (Loop b6–b7) and positioning the A1408
nucleobase (Trp105 in Loop b4–b5), a binding-induced
conformational change could be relayed to activate
methyltransfer. Indeed, the conformational restriction of
the critical Trp105 (107 in NpmA) mirrors the changes
in this loop structure. Thus, the differences in the
SAM-bound NpmA may represent two relevant distinct
conformational states of the protein during the recogni-
tion process. In this regard, it is noteworthy that in KamB,
where the protein appears to be bound by the reaction
by-product SAH, this loop is in a third distinct conform-
ation with little secondary structure.
Many important questions remain regarding the speciﬁc
details of the target recognition mechanisms for both
families of aminoglycoside-resistance methyltransferases.
This aspect of enzyme function is likely to most
uniquely deﬁne their activity from other SAM-dependent
methyltransferases. High-resolution structural character-
ization of these enzymes bound to their 30S ribosomal
subunit target are thus urgently required to better
deﬁne target recognition mechanisms before these broad
aminoglycoside-resistance determinants proliferate further
among pathogenic bacterial strains.
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